Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kateryna Filonenko
Do We Need Maintenance With Anti-Cd20 Antibody After First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Management of Patients With Follicular Lymphoma Treated First Line With Obinutuzumab
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma
Chinese Journal of Cancer Research
Cancer Research
Oncology
M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy
British Journal of Haematology
Hematology
First-Line Therapy of CD20+ Diffuse Large B-Cell Lymphoma: Facts and Open Questions
Haematologica
Hematology
Do All Patients With Recurrent Ovarian Cancer Need Systemic Therapy?
Cancer
Cancer Research
Oncology
Secondary Antibody Deficiency: A Complication of Anti-Cd20 Therapy for Neuroinflammation
Journal of Neurology
Neurology
Pd-1 Immune Checkpoint Blockade Improves Anti-Cd20 Based Immunotherapy in Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
Noninvasive Phosphorus Magnetic Resonance Spectroscopic Imaging Predicts Outcome to First-Line Chemotherapy in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma
Academic Radiology
Nuclear Medicine
Radiology
Imaging